I. E. Eryılmaz Et Al. , "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions," NEUROLOGICAL RESEARCH , vol.39, no.11, pp.965-972, 2017
Eryılmaz, I. E. Et Al. 2017. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. NEUROLOGICAL RESEARCH , vol.39, no.11 , 965-972.
Eryılmaz, I. E., Çeçener, G., Erer, S., Egeli, Ü., Tunca, B., Zarifoğlu, M., ... Elibol, B.(2017). Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. NEUROLOGICAL RESEARCH , vol.39, no.11, 965-972.
Eryılmaz, IŞIL Et Al. "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions," NEUROLOGICAL RESEARCH , vol.39, no.11, 965-972, 2017
Eryılmaz, IŞIL E. Et Al. "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions." NEUROLOGICAL RESEARCH , vol.39, no.11, pp.965-972, 2017
Eryılmaz, I. E. Et Al. (2017) . "Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions." NEUROLOGICAL RESEARCH , vol.39, no.11, pp.965-972.
@article{article, author={IŞIL EZGİ ERYILMAZ Et Al. }, title={Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions}, journal={NEUROLOGICAL RESEARCH}, year=2017, pages={965-972} }